Company Filing History:
Years Active: 2009-2012
Title: Innovations by Sean McDonald in Chemotherapy Efficacy
Introduction
Sean McDonald is an accomplished inventor based in Pittsburgh, PA, known for his significant contributions to the field of oncology. He holds five patents that focus on improving the efficacy of chemotherapeutic agents and monitoring patient responses to treatment. His work aims to enhance the precision of cancer therapies, ultimately benefiting patient outcomes.
Latest Patents
One of McDonald's latest patents is titled "Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics." This patent discusses an improved and unified system for monitoring the progression of individual patient malignancies. The assays, methods, tools, and systems outlined in this patent are designed to identify cellular and secreted markers, screen cells for phenotypic and genotypic drift, and predict the chemotherapeutic response of patient tumor cells to various therapeutic agents. Another notable patent is "Methods for assessing efficacy of chemotherapeutic agents." This invention provides methods for accurately predicting the efficacy of chemotherapeutic agents, increasing the positive predictive value of chemosensitivity assays by evaluating both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance. The results obtained from these methods offer insights into the in vivo effectiveness of therapies, leading to more effective treatment options for patients.
Career Highlights
Sean McDonald is currently associated with Precision Therapeutics, Inc., where he continues to innovate in the field of cancer treatment. His work has been pivotal in developing methodologies that enhance the understanding of how different therapies can be tailored to individual patient needs.
Collaborations
Throughout his career, McDonald has collaborated with notable professionals in the field, including Paul L Kornblith and Michael J Gabrin. These collaborations have further enriched his research and development efforts, contributing to advancements in cancer treatment.
Conclusion
Sean McDonald is a prominent inventor whose work in chemotherapy efficacy and patient monitoring is making a significant impact in oncology. His innovative patents and ongoing contributions to Precision Therapeutics, Inc. highlight his commitment to improving cancer treatment outcomes.